YOLFTbeta
32

Sagittarius Life Science

3205 · TWO · Healthcare / Biotechnology

44.35TWD-0.45 (-1.00%)

Price History

Full chart

Market Stats

Previous Close44.80
Open44.80
Day Range44.35 – 45.10
52-Week Range43.95 – 67.00
Volume71.00K
Market Cap3.19B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.12
Dividend Yield0.00%
Beta0.30
50-Day Avg47.57
200-Day Avg51.55

About

Sagittarius Life Science Corp engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology, as well as meat products. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODi-Miao Wu
  • Employees0
  • HeadquartersNo.3, Yuanqu Street, Taipei, Taiwan, Taiwan
  • Websitehttps://www.naturalbiokey.com

Leadership

  • Di-Miao WuAccounting Supervisor

Financials

Income Statement

Currency: TWD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.24B1.38B462.82M411.41M438.71M558.18M587.61M529.07M440.46M467.75M346.08M
Growth (%)-+11.65%-66.57%-11.11%+6.64%+27.23%+5.27%-9.96%-16.75%+6.20%-26.01%
Cost of Revenue753.82M808.42M344.07M348.29M369.61M448.32M487.07M446.50M368.98M386.64M288.37M
Gross Profit486.11M575.93M118.75M63.12M69.11M109.86M100.54M82.56M71.48M81.11M57.71M
Gross Margin39.20%41.60%25.66%15.34%15.75%19.68%17.11%15.61%16.23%17.34%16.68%
Operating Expense184.58M217.70M201.03M177.74M174.20M183.53M187.61M158.83M128.22M142.67M116.22M
Operating Income301.52M358.23M-82.28M-114.63M-105.10M-73.67M-87.07M-76.27M-56.74M-61.56M-58.51M
Operating Margin24.32%25.88%-17.78%-27.86%-23.96%-13.20%-14.82%-14.42%-12.88%-13.16%-16.91%
EBITDA---109.63M-102.17M-83.66M-47.64M-62.90M-55.35M-41.71M-34.72M-39.47M
EBITDA Margin---23.69%-24.83%-19.07%-8.53%-10.70%-10.46%-9.47%-7.42%-11.40%
Net Income300.70M268.19M-114.21M-91.81M-119.51M-74.12M-86.42M-74.20M-55.04M-48.53M-49.56M
Net Income Margin24.25%19.37%-24.68%-22.32%-27.24%-13.28%-14.71%-14.02%-12.50%-10.38%-14.32%
R&D29.18M31.46M26.99M24.80M28.57M24.86M31.58M22.69M21.83M17.89M21.50M
R&D as % of Total Revenue2.35%2.27%5.83%6.03%6.51%4.45%5.37%4.29%4.96%3.83%6.21%
Interest Expense0000246.00K330.00K388.00K234.00K82.00K207.00K68.00K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.06%0.06%0.07%0.04%0.02%0.04%0.02%

Balance Sheet

Currency: TWD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.13B1.41B1.06B893.75M811.59M740.74M675.75M579.12M664.72M519.83M1.07B
Total Liabilities416.95M200.51M97.16M96.38M137.09M152.36M144.03M123.70M137.82M100.07M26.91M
Total Equity714.71M1.21B965.47M797.37M674.02M586.22M516.77M441.79M514.65M408.35M1.04B
Cash420.69M869.07M833.16M648.12M522.52M394.24M255.66M189.48M133.89M83.79M151.55M
Total Debt-----37.64M24.00M11.37M13.32M--
Net Debt------356.60M-231.66M-178.11M-120.57M--

Cash Flow

Currency: TWD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow237.94M360.37M-23.31M-57.86M-104.50M-62.24M-29.18M-52.89M-69.37M-44.48M-36.05M
Investing Cash Flow-62.23M-84.52M116.43M-74.06M-10.85M-42.11M-104.82M----
Financing Cash Flow92.52M175.90M-127.97M-52.54M-9.60M-23.44M-4.16M-13.16M-7.89M--
Capital Expenditure2.95M19.76M2.90M101.00K14.69M11.20M8.43M1.09M2.01M3.80M404.00K
Free Cash Flow---26.23M-58.30M-119.48M-73.44M-37.61M-53.98M-71.38M-48.28M-36.45M
Dividends Paid85.62M85.62M131.09M52.60M-------
FCF to OCF--112.50%100.77%114.33%117.99%128.89%102.07%102.90%108.55%101.12%
Dividend Paid to FCF---499.81%-90.22%-------

Earnings

Report DateMar 31, 2020May 11, 2020Aug 10, 2020Nov 9, 2020Mar 29, 2021May 12, 2021Aug 11, 2021Nov 10, 2021Mar 23, 2022
EPS Estimate---------
EPS Actual-1.35-0.31-0.72-0.64-0.59-0.68-0.56-0.72-0.69
Surprise---------
TimingAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap3.19B
Enterprise Value2.59B
Trailing P/E0.00
Forward P/E0.00
Price / Sales6.82
Price / Book3.15
EPS-0.12
Book Value14.82
Revenue (TTM)467.69M
Gross Profit (TTM)42.12M
EBITDA-30.45M
Profit Margin-3.52%
Operating Margin-3.31%
Return on Equity-1.72%
Return on Assets-1.80%
Shares Outstanding67.55M
Shares Float17.48M
Beta0.30
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20181×
1.60Aug 31, 2018
20171×
4.00Aug 30, 2017
20161×
2.76Aug 17, 2016

Stock Splits

  • Aug 17, 20161048.659:1000
  • Nov 17, 20090.3368:1